HUTCHMED (LON:HCM) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

HUTCHMED (China) Limited (LON:HCM) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 261.04 ($3.36) and traded as low as GBX 248 ($3.20). HUTCHMED shares last traded at GBX 248 ($3.20), with a volume of 20,179 shares traded.

HUTCHMED Trading Up 4.4 %

The stock has a market cap of £2.81 billion, a P/E ratio of -66.10 and a beta of 0.76. The company has a current ratio of 2.81, a quick ratio of 2.97 and a debt-to-equity ratio of 11.97. The business’s fifty day simple moving average is GBX 234.83 and its 200 day simple moving average is GBX 261.04.

About HUTCHMED

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.

We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.

HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).